• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对963例膀胱移行细胞癌患者进行根治性兆伏级X线治疗的一系列结果。

The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.

作者信息

Duncan W, Quilty P M

出版信息

Radiother Oncol. 1986 Dec;7(4):299-310. doi: 10.1016/s0167-8140(86)80059-7.

DOI:10.1016/s0167-8140(86)80059-7
PMID:3101140
Abstract

The results are reported of a large series of patients with transitional cell cancer of the bladder, treated in Edinburgh between 1971 and 1982. Analysis of pre-treatment characteristics for patients with transitional cell bladder cancer showed that tumour category was significantly associated with grade and tumour size. Complete local tumour regression at follow-up cystoscopy was achieved in 45.9% of patients who completed radical megavoltage X-ray therapy. Patients with grade 2 or 3 cancer, a solid cancer or a tumour of less than 8 cm in size had significantly improved complete regression rates. Lasting local tumour control after initial complete regression was better in patients with grade 3 cancer. Complete regression was associated with improved survival for all but patients with T1 cancer. The poorest (uncorrected) survival rates were seen in patients over 79 years of age, those with T4 cancer, an ulcerated cancer, a grade 3 cancer or a tumour of more than 7 cm in size. Metastases were more often seen in patients with grade 3 or T3/T4 cancer. Severe late radiation-related complications were seen in 14.8% of patients.

摘要

报告了1971年至1982年在爱丁堡接受治疗的一大系列膀胱移行细胞癌患者的结果。对膀胱移行细胞癌患者的治疗前特征分析表明,肿瘤类别与分级和肿瘤大小显著相关。在完成根治性兆伏级X线治疗的患者中,45.9%在随访膀胱镜检查时实现了局部肿瘤完全消退。2级或3级癌症、实体癌或大小小于8 cm的肿瘤患者的完全消退率显著提高。3级癌症患者在初始完全消退后实现持久局部肿瘤控制的情况更好。除T1期癌症患者外,完全消退与生存率提高相关。79岁以上患者、T4期癌症患者、溃疡型癌症患者、3级癌症患者或大小超过7 cm的肿瘤患者的(未经校正的)生存率最差。3级或T3/T4期癌症患者更常出现转移。14.8%的患者出现严重的晚期放射相关并发症。

相似文献

1
The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.对963例膀胱移行细胞癌患者进行根治性兆伏级X线治疗的一系列结果。
Radiother Oncol. 1986 Dec;7(4):299-310. doi: 10.1016/s0167-8140(86)80059-7.
2
Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy.膀胱癌的预后指标:对主要接受根治性兆伏级X线治疗的膀胱移行细胞癌患者的分析
Radiother Oncol. 1986 Dec;7(4):311-21. doi: 10.1016/s0167-8140(86)80060-3.
3
Do normal mucosal biopsies predict prognosis in patients with transitional cell carcinoma of bladder treated by radical radiotherapy?正常黏膜活检能否预测接受根治性放疗的膀胱移行细胞癌患者的预后?
Br J Urol. 1987 Mar;59(3):242-7. doi: 10.1111/j.1464-410x.1987.tb04615.x.
4
Treatment of superficial (T1) tumours of the bladder by radical radiotherapy.
Br J Urol. 1986 Apr;58(2):147-52. doi: 10.1111/j.1464-410x.1986.tb09015.x.
5
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution.
Clin Oncol (R Coll Radiol). 2006 Feb;18(1):52-9. doi: 10.1016/j.clon.2005.06.015.
6
Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.顺铂与多西他赛同步化疗联合外照射根治性放疗用于浸润性移行细胞膀胱癌患者:耐受性及局部控制的初步报告
Anticancer Res. 1997 Nov-Dec;17(6D):4771-80.
7
Radiotherapy and cystectomy for T3 bladder carcinoma.T3期膀胱癌的放射治疗与膀胱切除术
Br J Urol. 1981 Dec;53(6):598-601. doi: 10.1111/j.1464-410x.1981.tb03269.x.
8
Assessment of factors influencing the outcome of radiotherapy for bladder cancer.
Br J Urol. 1990 Sep;66(3):288-93. doi: 10.1111/j.1464-410x.1990.tb14929.x.
9
The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation.血红蛋白水平对膀胱移行细胞癌光子照射后消退及长期局部控制的影响。
Int J Radiat Oncol Biol Phys. 1986 Oct;12(10):1735-42. doi: 10.1016/0360-3016(86)90313-5.
10
Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.
J Urol. 1989 Dec;142(6):1448-53; discussion 1453-4. doi: 10.1016/s0022-5347(17)39122-x.

引用本文的文献

1
Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.肌层浸润性膀胱癌的膀胱保留治疗:全面综述。
Int Braz J Urol. 2020 Mar-Apr;46(2):169-184. doi: 10.1590/S1677-5538.IBJU.2020.99.01.
2
Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder Cancer.靶向肿瘤:评估膀胱癌患者膀胱体积和位置对放射治疗准确性的影响
Cureus. 2017 Sep 1;9(9):e1638. doi: 10.7759/cureus.1638.
3
Landmarks in the treatment of muscle-invasive bladder cancer.肌层浸润性膀胱癌的治疗里程碑。
Nat Rev Urol. 2017 Sep;14(9):565-574. doi: 10.1038/nrurol.2017.82. Epub 2017 Jul 4.
4
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.非转移性肌肉浸润性膀胱癌治疗:AUA/ASCO/ASTRO/SUO 指南。
J Urol. 2017 Sep;198(3):552-559. doi: 10.1016/j.juro.2017.04.086. Epub 2017 Apr 26.
5
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers.肌肉浸润性膀胱癌的膀胱保留治疗方法
Curr Treat Options Oncol. 2016 Mar;17(3):15. doi: 10.1007/s11864-016-0390-8.
6
Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer.同步放化疗可改善肌层浸润性膀胱癌的生存结局。
Radiat Oncol J. 2015 Dec;33(4):294-300. doi: 10.3857/roj.2015.33.4.294. Epub 2015 Dec 30.
7
Multimodal management of muscle-invasive bladder cancer.肌层浸润性膀胱癌的多模式管理
Curr Probl Cancer. 2014 May-Jun;38(3):80-108. doi: 10.1016/j.currproblcancer.2014.06.001. Epub 2014 Jun 23.
8
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).随机非劣效性试验:对于肌层浸润性膀胱癌,低剂量大体积放疗与标准剂量体积放疗的比较:BC2001 试验(CRUK/01/004)结果。
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):261-9. doi: 10.1016/j.ijrobp.2013.06.2044.
9
CIP2A protein expression in high-grade, high-stage bladder cancer.CIP2A 蛋白在高级别、高分期膀胱癌中的表达。
Cancer Med. 2012 Aug;1(1):76-81. doi: 10.1002/cam4.15. Epub 2012 Jul 15.
10
Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder.HER-2 的过度表达与膀胱癌的分期有关。
Libyan J Med. 2012;7. doi: 10.3402/ljm.v7i0.14694. Epub 2012 Mar 8.